Monitoring the normal growth of a child is one of the primary tasks of a pediatric endocrinologist. The most common abnormality of growth is a variety of options for its delay, detected in 3% of children. Much less often, the reason for a visit to the doctor is tallness. The most adverse cause of gigantism in children for health and life is conditions accompanied by hyperproduction of growth hormone (GH). In pediatric practice, the latter, admittedly, constitute an endocrine rarity. Thus, according to 11-year observations of more than 800 children at the Outpatient Center for Pediatric Endocrinology at North Shore University Hospital in the United States, in the structure of the growth pathology, the height rate was 2.5% - approximately 75 cases per 100,000 children. At the same time, for each case of seeking advice about excessive growth, there were about 40 appeals due to its delay. True gigantism is found only in every 5th child with unusually high growth, or less than 0.5% among children with deviations in body length. On the other hand, according to M. I. Balabolkin, only 9% of patients with acromegaly debut of the disease occurs at the age of 20. These statistics once again emphasize the extreme rarity of diseases occurring with abnormal excess growth in childhood.
The most important problem of modern clinical diabetology is the prevention and treatment of late complications of diabetes. Until recently, it was believed that the prevention and treatment of diabetic microvascular lesions was mainly a problem for endocrinologists. However, to date it has been reliably established that diabetic complications not only develop more often in patients with insulin-dependent diabetes mellitus (IDDM) in childhood, but are also widespread among children and especially adolescents [1, 2].
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.